title: Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors.
abstract: Recent studies have shown that the brain is not a barrier to successful active immunotherapy that uses gene-modified autologous tumor cell vaccines. In this study, we compared the efficacy of two types of vaccines for the treatment of tumors within the central nervous system (CNS): dendritic cell (DC)-based vaccines pulsed with either tumor extract or tumor RNA, and cytokine gene-modified tumor vaccines. Using the B16/F10 murine melanoma (B16) as a model for CNS tumor, we show that vaccination with bone marrow-generated DCs, pulsed with either B16 cell extract or B16 total RNA, can induce specific cytotoxic T lymphocytes against B16 tumor cells. Both types of DC vaccines were able to protect animals from tumors located in the CNS. DC-based vaccines also led to prolonged survival in mice with tumors placed before the initiation of vaccine therapy. The DC-based vaccines were at least as effective, if not more so, as vaccines containing B16 tumor cells in which the granulocytic macrophage colony-stimulating factor gene had been modified. These data support the use of DC-based vaccines for the treatment of patients with CNS tumors.
authors.affiliation: Department of Pediatrics, Duke University Medical Center, Durham, North Carolina 27710, USA.
authors.forename: D M
authors.initials: DM
authors.lastname: Ashley
authors.forename: B
authors.initials: B
authors.lastname: Faiola
authors.forename: S
authors.initials: S
authors.lastname: Nair
authors.forename: L P
authors.initials: LP
authors.lastname: Hale
authors.forename: D D
authors.initials: DD
authors.lastname: Bigner
authors.forename: E
authors.initials: E
authors.lastname: Gilboa
mesh_terms: D000818:Animals; D001854:Bone Marrow Cells; D019496:Cancer Vaccines / Q000276:immunology; D002457:Cell Extracts / Q000276:immunology; D016543:Central Nervous System Neoplasms / Q000235:genetics / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D003713:Dendritic Cells / Q000276:immunology*; D006651:Histocytochemistry; D007167:Immunotherapy; D008546:Melanoma, Experimental / Q000235:genetics / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D051379:Mice; D012334:RNA, Neoplasm / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D014407:Tumor Cells, Cultured
chemical_list: D019496:Cancer Vaccines; D002457:Cell Extracts; D012334:RNA, Neoplasm